Rajesh, S., Zhai, J., Drummond, C. J., & Tran, N. (2022, October). Novel pH-Responsive Cubosome and Hexosome Lipid Nanocarriers of SN-38 Are Prospective for Cancer Therapy. Pharmaceutics.
Chicago Style (17th ed.) CitationRajesh, Sarigama, Jiali Zhai, Calum J. Drummond, and Nhiem Tran. "Novel PH-Responsive Cubosome and Hexosome Lipid Nanocarriers of SN-38 Are Prospective for Cancer Therapy." Pharmaceutics Oct. 2022.
MLA (9th ed.) CitationRajesh, Sarigama, et al. "Novel PH-Responsive Cubosome and Hexosome Lipid Nanocarriers of SN-38 Are Prospective for Cancer Therapy." Pharmaceutics, Oct. 2022.
Warning: These citations may not always be 100% accurate.
